Kimble Eric Wilson 4
4 · Entasis Therapeutics Holdings Inc. · Filed Jan 27, 2020
Insider Transaction Report
Form 4
Kimble Eric Wilson
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
[F1]2020-01-23+50,000→ 50,000 totalExercise: $4.94Exp: 2030-01-22→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on January 1, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Signature
Elizabeth M. Keiley as Attorney-in-Fact for Eric Wilson Kimble|2020-01-27